Evidence map›Paper›PMID 33671102›Full record

ArticleAntibiotics (Basel, Switzerland)2021

High Risk Clone: A Proposal of Criteria Adapted to the One Health Context with Application to Enterotoxigenic

Maud de Lagarde, Ghyslaine Vanier, Julie Arsenault, John Morris Morris Fairbrother

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Genomic Profiling of Multidrug-Resistant SwineAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Description of Antimicrobial-ResistantVeterinary sciences · 2023
    Article
  15. Article
  16. Microorganisms · 2022
    Article
  17. Antimicrobial Resistance and Virulence Characteristics ofPathogens (Basel, Switzerland) · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maud de LagardeOIE Reference Laboratory for Escherichia coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S2M2, Canada.
Ghyslaine VanierOIE Reference Laboratory for Escherichia coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S2M2, Canada.
Julie ArsenaultSwine and Poultry Infectious Research Center (CRIPA-FQRNT), Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S2M2, Canada.ORCID 0000-0001-8382-7326
John Morris Morris FairbrotherOIE Reference Laboratory for Escherichia coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S2M2, Canada.
Université de Montréal · CA

Funding

Consortium de recherche et innovations en bioprocédés industriels au Québec (CRIBIQ) 2016-047-C22Fonds de Recherche du Québec - Nature et Technologies CRIP Regroupements stratégiques 111946• Groupe de Recherche en Zoonoses et Santé Publique (GREZOSP) of the Université de Montréal -John-R. Evans Leaders Funds of the Canada foundation 37949Ministère de l'agriculture, des pêcheries et de l'alimentation du Québec (MAPAQ), Programme Innov'Action 116645Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2018-06560
6 · The paper itself

Abstract

The definition of a high risk clone for antibiotic resistance dissemination was initially established for human medicine. We propose a revised definition of a high risk clone adapted to the One Health context. Then, we applied our criteria to a cluster of enrofloxacin non susceptible ETEC:F4 isolates which emerged in 2013 in diseased pigs in Quebec. The whole genomes of 183 ETEC:F4 strains isolated in Quebec from 1990 to 2018 were sequenced. The presence of virulence and resistance genes and replicons was examined in 173 isolates. Maximum likelihood phylogenetic trees were constructed based on SNP data and clones were identified using a set of predefined criteria. The strains belonging to the clonal lineage ST100/O149:H10 isolated in Quebec in 2013 or later were compared to ETEC:F4 whole genome sequences available in GenBank. Prior to 2000, ETEC:F4 isolates from pigs in Quebec were mostly ST90 and belonged to several serotypes. After 2000, the isolates were mostly ST100/O149:H10. In this article, we demonstrated the presence of a ETEC:F4 high risk clone. This clone (1) emerged in 2013, (2) is multidrug resistant, (3) has a widespread distribution over North America and was able to persist several months on farms, and (4) possesses specific virulence genes. It is crucial to detect and characterize high risk clones in animal populations to increase our understanding of their emergence and their dissemination.

Indexed as

antimicrobial resistanceEscherichia coliETEC:F4fluoroquinolones non-susceptibilitygenomicsmultidrug resistanceNorth Americapigs

Identifiers

PMID33671102
PMCPMC8000703
OpenAlexW3134469697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.